Home » Topics » BioWorld Science

BioWorld Science
RSS

Zynaxis to develop Zyn-Linker form of heparin under SBIR grant

Aug. 16, 1996

Kanebo reports Na+/H+ exchange inhibitors

Aug. 16, 1996

Antihypertensive quinazoline derivatives described by Nippon Chemiphar

Aug. 16, 1996

American Cyanamid claims vasopressin antagonists

Aug. 16, 1996

Pseudostat enters phase II in CF patients

Aug. 16, 1996

LMA-Flexible introduced by Gensia

Aug. 16, 1996

SKB discloses drugs for IL-8-mediated disorders

Aug. 16, 1996

IL-8 role in emphysema and asthma suggested

Aug. 16, 1996

PDE IV inhibitors claimed by Euroceltique

Aug. 16, 1996

Roche Bioscience, LeukoSite to investigate drugs for allergy and asthma

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...